Healthcare Services

Human Growth Hormone Market Forecast (2026–2030): Long-Term Insights

April 22, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Human Growth Hormone Market Between 2026 And 2030?

The human growth hormone market has demonstrated significant expansion in recent times. It is projected to expand from $5.18 billion in 2025 to reach $5.68 billion by 2026, reflecting a compound annual growth rate (CAGR) of 9.5%. Historically, this expansion has been driven by several factors, including an increase in the diagnosis of growth hormone deficiency, the broadening of recombinant hormone production, enhanced awareness regarding pediatric growth disorders, an increase in the availability of branded HGH therapies, and the sustained clinical utilization of hormone replacement.

The human growth hormone market is projected to experience substantial expansion in the coming years. This market is forecast to reach $7.87 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.5%. This anticipated growth during the forecast period is driven by several factors, including an escalating demand for long-acting growth hormone treatments, a rising incidence of adult growth hormone deficiency, a heightened emphasis on individualized endocrine therapies, the expansion of specialty pharmacy distribution channels, and increased investment in hormone therapy research. Key trends identified for the forecast period encompass an increasing need for growth hormone deficiency treatments, a growing uptake of long-acting growth hormone formulations, expanding application of hgh within pediatric endocrinology, the broadened availability of recombinant growth hormone therapies, and a stronger focus on patient adherence combined with convenient administration methods.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/human-growth-hormone-global-market-report

Which Key Factors Are Driving The Human Growth Hormone Market Growth?

The increasing number of older individuals is projected to fuel the expansion of the human growth hormone market in the coming years. An aging population is characterized by a higher percentage of elderly people in a society, resulting from longer lifespans and lower birth rates. This demographic shift towards an older population is being propelled by improvements in healthcare that have extended life expectancy. The older demographic utilizes human growth hormone, under medical guidance, to combat age-associated issues such as muscle deterioration, reduced vitality, and metabolic slowdown. For example, the Population Reference Bureau, a US-based non-profit organization, stated in January 2024, that the population of Americans aged 65 and above is anticipated to climb from 58 million in 2022 to 82 million by 2050, representing a 47% surge. Consequently, the share of this age bracket within the total U.S. population will increase from 17% to 23% over this timeframe. Thus, the growing aging population is propelling the growth of the human growth hormone market.

What Segment Categories Shape The Human Growth Hormone Market Segment Landscape?

The human growth hormone market covered in this report is segmented –

1) By Product: Liquid, Powder

2) By Brand: Norditropin, Genotropin, Humatrope, Saizen, Omnitrope, Skytrofa, Other Brands

3) By Route Of Administration: Intramuscular, Subcutaneous

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Specialty Pharmacy

5) By Application: Growth Hormone (GH) Deficiency, Adult Growth Hormone (GH) Deficiency, Pediatric Growth Hormone (GH) Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, Small For Gestational Age, Other Applications

Subsegments:

1) By Liquid: Pre-Filled Liquid Syringes, Vials Of Liquid Growth Hormone

2) By Powder: Reconstitutable Powder, Freeze-Dried Powder

Which Trends Are Guiding The Direction Of The Human Growth Hormone Market?

Leading companies in the human growth hormone market are intensifying their efforts on drug development and seeking regulatory approvals to advance their medication offerings and deliver enhanced treatment solutions. Drug development is an intricate and demanding process, involving several stages to guarantee a new drug’s safety, effectiveness, and quality before its release to the market. For instance, in June 2023, Pfizer Inc., a US-based biopharmaceutical company, and OPKO Health Inc., a US-based biopharmaceutical and diagnostics company, disclosed the Food and Drug Administration (FDA) approval of NGENLA (somatrogon-ghla). This therapy provides a more convenient dosing schedule and improves patient compliance compared to daily injections. It allows children with growth hormone deficiency to reduce the frequency of injections from daily to once a week. The FDA’s approval was based on a Phase 3 study which indicated NGENLA’s non-inferiority when compared to once-daily somatropin, along with a safety profile similar to somatropin.

Who Are The Companies Operating Across The Human Growth Hormone Market Value Chain?

Major companies operating in the human growth hormone market are Pfizer Inc., Roche Holding AG, Novartis AG, Thermo Fisher Scientific Inc., Eli Lilly and Company, Novo Nordisk A/S, Merck KGaA, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Ipsen Pharma, Ferring Holding SA, Endo International, Zydus Lifesciences Limited, Opko Health, LG Life Sciences, EMD Serono Inc., Wockhardt Ltd., JCR Pharmaceuticals Co. Ltd., Genentech Inc., SOFAR S.p.A., United Laboratories, Ascendis Pharma, Uni-Pharma S.A., Versartis Inc., Reliance Life Sciences, Anhui Anke Biotechnology (Group) Co. Ltd., Rani Therapeutics

Get The Full Human Growth Hormone Market Report:

https://www.thebusinessresearchcompany.com/report/human-growth-hormone-global-market-report

Which Region Accounts For The Largest Portion Of The Human Growth Hormone Market?

North America was the largest region in the human growth hormone market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human growth hormone market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Human Growth Hormone Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/human-growth-hormone-global-market-report

Browse Through More Reports Similar to the Global Human Growth Hormone Market 2026, By The Business Research Company

Bone Growth Stimulator Market Report 2026

https://www.thebusinessresearchcompany.com/report/bone-growth-stimulator-global-market-report

Hormone Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/hormone-therapy-global-market-report

Bioidentical Hormones Market Report 2026

https://www.thebusinessresearchcompany.com/report/bioidentical-hormones-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795